Cancer medicines
Olaparib
Olaparib
An oral PARP inhibitor used under specific genetic and treatment conditions.
Sources checked · Introductory guide
On this page
How it works
It inhibits PARP, an enzyme involved in DNA repair.[1]
Where it is used
Used in selected ovarian, breast, pancreatic and prostate cancers after reviewing genetic results and prior therapy.[1]
Key safety points
Regular blood counts and interaction checks are needed. Report severe fatigue, fever or new breathing difficulty immediately.[2]
Questions for your care team
- Which test results and treatment responses support choosing this drug?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.